Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,800
Closed -$468K 380
2023
Q1
$468K Sell
5,800
-9,330
-62% -$751K 0.06% 241
2022
Q4
$1.13M Sell
15,130
-220
-1% -$15.7K 0.16% 158
2022
Q3
$990K Sell
15,350
-2,200
-13% -$152K 0.16% 156
2022
Q2
$1.22M Sell
17,550
-3,600
-17% -$267K 0.19% 141
2022
Q1
$1.63M Sell
21,150
-23,000
-52% -$1.65M 0.23% 123
2021
Q4
$3.38M Buy
44,150
+19,060
+76% +$1.4M 0.48% 56
2021
Q3
$1.85M Buy
25,090
+15,260
+155% +$1.14M 0.29% 91
2021
Q2
$656K Sell
9,830
-11,830
-55% -$791K 0.1% 176
2021
Q1
$1.61M Buy
21,660
+14,250
+192% +$1.08M 0.26% 106
2020
Q4
$540K Buy
+7,410
New +$523K 0.1% 189

Other funds holding HOLX

Cozad Asset Management's HOLX Position: Q2 2023 in Review

Cozad Asset Management sold out of Hologic (HOLX) in Q2 2023, closing a stake of 5,800 shares — an estimated $468K sold.

Cozad Asset Management first reported a position in HOLX in Q4 2020 and held it in 10 quarters. The position peaked at $3.38M in Q4 2021. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Cozad Asset Management reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Cozad Asset Management sold 5,800 Hologic shares in Q2 2023, an estimated $468K.
  • Cozad Asset Management first reported a position in Hologic in Q4 2020 and held it in 10 quarters.
  • Cozad Asset Management's Hologic position peaked at $3.38M in Q4 2021.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Cozad Asset Management's 13F filing for Q2 2023, filed 26 Jul 2023.